cbdMD, Inc. Form 8-K Summary
Business Context and Reporting Period
cbdMD, Inc. (YCBD), an emerging growth company incorporated in North Carolina, filed this Current Report on December 22, 2020. The filing serves as a Regulation FD disclosure announcing financial and operating results for the fourth quarter and fiscal year ended September 30, 2020.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release (Exhibit 99.1) and earnings call script (Exhibit 99.2) referenced in the report but are not detailed in the body of this Form 8-K.
Material Changes
No specific material changes or comparative financial data are disclosed in the text of this filing. The document solely references the announcement of results for the period ended September 30, 2020.
Guidance, Outlook, and Risks
Management hosted a conference call on December 22, 2020, to discuss the results. The script for this presentation is furnished as Exhibit 99.2. The filing explicitly states that the information in Item 7.01, including the exhibits, is furnished and not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it incorporated by reference into other filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for Q4 and FY 2020.
- Examine Exhibit 99.2 (Earnings Call Script) for management's guidance, outlook, and discussion of operational risks.
- Verify the company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.
- Confirm the trading symbols YCBD (Common Stock) and YCBDpA (8.0% Series A Cumulative Convertible Preferred Stock) on the NYSE American.